Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Desplats, Paula ^a   Dumaop, Wilmar ^b   Cronin, Peter ^a   Gianella, Sara ^c   Woods, Steven ^d   Letendre, Scott ^c   Smith, David ^c   Masliah, Eliezer ^a,b   Grant, Igor ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 1; DOPAMINE; GENOMIC DNA; MESSENGER RNA; METHAMPHETAMINE; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1;

ADULT; ARTICLE; BRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; EPIGENETICS; FEMALE; FRONTAL CORTEX; GENE MUTATION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; MALE; MEDICAL HISTORY; METHAMPHETAMINE DEPENDENCE; NERVE DEGENERATION; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; AUTOPSY; DRUG ABUSE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIROLOGY; WESTERN BLOTTING;

ADULT; AMPHETAMINE-RELATED DISORDERS; AUTOPSY; BLOTTING, WESTERN; BRAIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE REGULATORY NETWORKS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84904634900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102555     Document Type: Article

References (51)

1. Fauci AS (1988) The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239: 617-622.
2. Portegies P, Brew BJ (1991) Update on HIV-related neurological illness. AIDS 5 Suppl 2: S211-217.
3. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. Journal of neurovirology 17: 3-16.
4. Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, et al. (2007) Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 196: 361-370. (Pubitemid 47093886)
5. Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, et al. (2013) Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS patient care and STDs 27: 5-16.
6. NIDA (2004) Drug abuse and AIDS. NIDA InfoFacts.
7. Ferris MJ, Mactutus CF, Booze RM (2008) Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci Biobehav Rev 32: 883-909.
8. Cadet JL, Krasnova IN (2007) Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation. Neurotox Res 12: 181-204.
9. Toussi SS, Joseph A, Zheng JH, Dutta M, Santambrogio L, et al. (2009) Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication. AIDS Res Hum Retroviruses 25: 1117-1121.
10. Marquine MJ, Iudicello JE, Morgan EE, Brown GG, Letendre SL, et al. (2014) "Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency. Psychiatry research 215: 208-216.
11. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Heaton RK, et al. (2006) Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav 10: 185-190.
12. Chana G, Everall IP, Crews L, Langford D, Adame A, et al. (2006) Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users. Neurology 67: 1486-1489. (Pubitemid 44632083)
13. Langford D, Adame A, Grigorian A, Grant I, McCutchan JA, et al. (2003) Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 34: 467-474. (Pubitemid 37500470)
14. Langford D, Grigorian A, Hurford R, Adame A, Crews L, et al. (2004) The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J Neurovirol 10: 327-337. (Pubitemid 40109620)
15. Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore DJ, et al. (2013) Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. Journal of addiction medicine 7: 255-263.
16. Doyle KL, Morgan EE, Morris S, Smith DM, Little S, et al. (2013) Real-world impact of neurocognitive deficits in acute and early HIV infection. Journal of neurovirology 19: 565-573.
17. Jing L, Liang JH (2008) [The influence of psychoactive substance on histone acetylation modification]. Sheng Li Ke Xue Jin Zhan 39: 221-224.
18. Numachi Y, Shen H, Yoshida S, Fujiyama K, Toda S, et al. (2007) Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain. Neurosci Lett 414: 213-217.
19. Desplats P, Dumaop W, Smith D, Adame A, Everall I, et al. (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80: 1415-1423.
20. Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, et al. (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 26: 412-423. (Pubitemid 46160942)
21. Shirazi J, Shah S, Sagar D, Nonnemacher MR, Wigdahl B, et al. (2013) Epigenetics, drugs of abuse, and the retroviral promoter. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 8: 1181-1196.
22. Marban C, Redel L, Suzanne S, Van Lint C, Lecestre D, et al. (2005) COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells. Nucleic Acids Res 33: 2318-2331. (Pubitemid 41439899)
23. Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, et al. (2009) CpG methylation controls reactivation of HIV from latency. PLoS Pathog 5: e1000554.
24. Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nature reviews Neuroscience 12: 623-637.
25. Renthal W, Nestler EJ (2009) Histone acetylation in drug addiction. Seminars in cell & developmental biology 20: 387-394.
26. Alexaki A, Quiterio SJ, Liu Y, Irish B, Kilareski E, et al. (2007) PMA-induced differentiation of a bone marrow progenitor cell line activates HIV-1 LTR-driven transcription. DNA and cell biology 26: 387-394. (Pubitemid 46981693)
27. Youngblood B, Reich NO (2008) The early expressed HIV-1 genes regulate DNMT1 expression. Epigenetics 3: 149-156.
28. Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, et al. (2006) Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20: 879-887. (Pubitemid 43731570)
29. Gianella S, Anderson CM, Vargas MV, Richman DD, Little SJ, et al. (2013) Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA. The Journal of infectious diseases 207: 898-902.
30. Desplats P, Spencer B, Coffee E, Patel P, Michael S, et al. (2011) Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. The Journal of biological chemistry 286: 9031-9037.
31. Downey T (2006) Analysis of a multifactor microarray study using Partek genomics solution. Methods in enzymology 411: 256-270.
32. Kibriya MG, Raza M, Jasmine F, Roy S, Paul-Brutus R, et al. (2011) A genome-wide DNA methylation study in colorectal carcinoma. BMC medical genomics 4: 50.
33. Eisenhart C (1947) The assumptions underlying the analysis of variance. Biometrics 3: 1-21.
34. Wojdacz TK, Borgbo T, Hansen LL (2009) Primer design versus PCR bias in methylation independent PCR amplifications. Epigenetics: official journal of the DNA Methylation Society 4: 231-234.
35. Bibikova M, Barnes B, Tsan C, Ho V, Klotzle B, et al. (2011) High density DNA methylation array with single CpG site resolution. Genomics 98: 288-295.
36. Masliah E, Dumaop W, Galasko D, Desplats P (2013) Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics: official journal of the DNA Methylation Society 8: 1030-1038.
37. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, et al. (2012) Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome biology 13: R43.
38. Mi H, Muruganujan A, Thomas PD (2013) PANTHER in 2013: modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic acids research 41: D377-386.
39. Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nature reviews Genetics 13: 484-492.
40. Wang J, Yuan W, Li MD (2011) Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/ methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses. Molecular neurobiology 44: 269-286.
41. Silverstein PS, Shah A, Gupte R, Liu X, Piepho RW, et al. (2011) Methamphetamine toxicity and its implications during HIV-1 infection. Journal of neurovirology 17: 401-415.
42. Suzuki Y, Craigie R (2007) The road to chromatin - nuclear entry of retroviruses. Nature reviews Microbiology 5: 187-196. (Pubitemid 46291278)
43. Pandhare J, Dash C (2011) A prospective on drug abuse-associated epigenetics and HIV-1 replication. Life sciences 88: 995-999.
44. Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E (2009) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 5: e1000495.
45. Palacios JA, Perez-Pinar T, Toro C, Sanz-Minguela B, Moreno V, et al. (2012) Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy. Journal of virology 86: 13081-13084.
46. Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nature reviews Neuroscience 8: 844-858. (Pubitemid 350006216)
47. Jayanthi S, McCoy MT, Chen B, Britt JP, Kourrich S, et al. (2013) Methamphetamine Downregulates Striatal Glutamate Receptors via Diverse Epigenetic Mechanisms. Biological psychiatry.
48. Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B (1994) Cerebrospinal fluid dopamine in HIV-1 infection. AIDS 8: 67-71. (Pubitemid 24094090)
49. Itoh K, Mehraein P, Weis S (2000) Neuronal damage of the substantia nigra in HIV-1 infected brains. Acta neuropathologica 99: 376-384. (Pubitemid 30179576)
50. Hermann-Kleiter N, Baier G (2010) NFAT pulls the strings during CD4+ T helper cell effector functions. Blood 115: 2989-2997.
51. Romanchikova N, Ivanova V, Scheller C, Jankevics E, Jassoy C, et al. (2003) NFAT transcription factors control HIV-1 expression through a binding site downstream of TAR region. Immunobiology 208: 361-365. (Pubitemid 38081359)